
     RDKit          2D

 22 22  0  0  1  0  0  0  0  0999 V2000
   -1.3184    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1434    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5559    0.5230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5559    1.9520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1434    2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5559    3.3809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3809    3.3809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7934    2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6184    2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0309    1.9520    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0309    3.3809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8559    3.3809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6184    4.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0309    4.8099    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7934    4.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3184    2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9059    3.3809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9059    1.9520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0809    1.9520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3316    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1566    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0809    0.5230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  0
  5  6  1  1
  5 16  1  0
  6  7  1  0
  7  8  2  0
  7 15  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB02598

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT01950

>  <COMMON_NAME>  (1) 
N-Alpha-Acetyl-3,5-Diiodotyrosylglycine

$$$$
